UB Paderborn / Katalog / Suche / in CDI

Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II

Folia biologica, 2004, Vol.50 (6), p.175-183

2004

Volltextzugriff (PDF)

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2436-2442

2010

Volltextzugriff (PDF)

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

Europace (London, England), 2011-05, Vol.13 (5), p.723-746

2011

Volltextzugriff (PDF)

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2018-10, Vol.16 (10), p.1994-2002

2018

Volltextzugriff (PDF)

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2194-2201

2016

Volltextzugriff (PDF)

External validation of the DASH prediction rule: a retrospective cohort study

Journal of thrombosis and haemostasis, 2017-10, Vol.15 (10), p.1963-1970

2017

Volltextzugriff (PDF)

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Haematologica (Roma), 2012-10, Vol.97 (10), p.1507-1513

2012

Volltextzugriff (PDF)

Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum)

Journal of thrombosis and haemostasis, 2012-06, Vol.10 (6), p.1026-1035

2012

Volltextzugriff (PDF)

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

International journal of cardiology, 2021-03, Vol.327, p.176-182

2021

Volltextzugriff (PDF)

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism

Journal of thrombosis and haemostasis, 2008-08, Vol.6 (8), p.1327-1333

2008

Volltextzugriff (PDF)

Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation

Europace (London, England), 2024-05, Vol.26 (Supplement_1)

2024

Volltextzugriff (PDF)

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.775-781

2015

Volltextzugriff (PDF)

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

The New England journal of medicine, 2001-07, Vol.345 (3), p.165-169

2001

Volltextzugriff (PDF)

Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry

Haematologica (Roma), 2008-02, Vol.93 (2), p.273-278

2008

Volltextzugriff (PDF)

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Circulation (New York, N.Y.), 2015-11, Vol.132 (20), p.1891-1897

2015

Volltextzugriff (PDF)

First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma

Haematologica (Roma), 2004-07, Vol.89 (7), p.826

2004

Volltextzugriff (PDF)

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

Journal of thrombosis and haemostasis, 2005-03, Vol.3 (3), p.459-464

2005

Volltextzugriff (PDF)

PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry

Thrombosis research, 2022-05, Vol.213, p.S39-S39

2022

Volltextzugriff (PDF)

Ischemic and bleeding risk stratification in diabetic patients after acute coronary syndrome based on insulin requirement

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis

Thrombosis and haemostasis, 2011-12, Vol.106 (6), p.997

2011

Volltextzugriff (PDF)

MACHINE LEARNING APPROACH FOR PREDICTION OF CLINICAL OUTCOMES IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION

European heart journal supplements, 2024-05, Vol.26 (Supplement_2), p.ii8-ii8

2024

Volltextzugriff (PDF)

D‐dimer levels and 15‐day outcome in acute pulmonary embolism. Findings from the RIETE Registry

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1795-1801

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II

Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

External validation of the DASH prediction rule: a retrospective cohort study

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry

A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum)

Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism

Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis

Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry

Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)

PO-58: Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry

Ischemic and bleeding risk stratification in diabetic patients after acute coronary syndrome based on insulin requirement

Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis

MACHINE LEARNING APPROACH FOR PREDICTION OF CLINICAL OUTCOMES IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION

D‐dimer levels and 15‐day outcome in acute pulmonary embolism. Findings from the RIETE Registry

Suchergebnisse filtern